SCHEMBL3535289

SCHEMBL3535289

NC(=O)c1cc(N2CCOCC2)ccc1N1CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.61
MAPT P10636 4/20 0.58
KDM4E B2RXH2 2/20 0.58
MEN1 O00255 1/20 0.58
THRB P10828 1/20 0.58
ALOX15 P16050 1/20 0.58
GFER P55789 1/20 0.58
YWHAG P61981 1/20 0.58
KMT2A Q03164 1/20 0.58
HSD17B10 Q99714 1/20 0.58
ALDH1A1 P00352 4/20 0.57
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 1/20 0.54
NPSR1 Q6W5P4 1/20 0.53
LGMN Q99538 1/20 0.50
PKM P14618 1/20 0.49
S100B P04271 1/20 0.49
PRKDC P78527 1/20 0.48
IP6K1 Q92551 1/20 0.48
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3536839 0.89 MAPT (0.56) HTTMAPTKDM4EMEN1THRB
SCHEMBL3537649 0.83 HTT (0.61) HTTMAPTKDM4EMEN1THRB
SCHEMBL4351617 0.82 PRKDC (0.59) HTTMAPTKDM4EMEN1ALOX15
SCHEMBL79339 0.80 KDM4E (0.74) HTTMAPTKDM4EMEN1THRB
SCHEMBL3120753 0.80 ALDH1A1 (0.54) HTTMAPTKDM4EMEN1THRB
SCHEMBL144733 0.80 LGMN (0.59) MAPTLGMNPRKDCIP6K1JAK2
SCHEMBL552259 0.80 PRKDC (0.60) MAPTLGMNPKMPRKDCJAK2
SCHEMBL3538450 0.79 NPC1 (0.63) HTTMAPTKDM4EMEN1THRB
SCHEMBL3228970 0.78 MAPT (0.56) HTTMAPTKDM4EMEN1ALOX15
SCHEMBL7449213 0.78 AKR1C3 (0.56) HTTMAPTKDM4EMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP claimed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP claimed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US claimed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO claimed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US disclosed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100201-A1 Inhibitors of c-fms kinase MUSK, FLT3, FES HTT 1421/4885MAPT 159/4885KDM4E 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.